Mapping of Pelvic Lymph Node Metastases in Prostate Cancer

被引:185
|
作者
Joniau, Steven [1 ]
Van den Bergh, Laura [2 ]
Lerut, Evelyne [3 ]
Deroose, Christophe M. [4 ]
Haustermans, Karin [2 ]
Oyen, Raymond [5 ]
Budiharto, Tom [2 ]
Ameye, Filip [1 ]
Bogaerts, Kris [6 ]
Van Poppel, Hein [1 ]
机构
[1] Katholieke Univ Leuven Hosp, Dept Urol, B-3000 Louvain, Belgium
[2] Katholieke Univ Leuven Hosp, Dept Radiat Oncol, B-3000 Louvain, Belgium
[3] Katholieke Univ Leuven Hosp, Dept Histopathol, B-3000 Louvain, Belgium
[4] Katholieke Univ Leuven Hosp, Dept Nucl Med, B-3000 Louvain, Belgium
[5] Katholieke Univ Leuven Hosp, Dept Radiol, B-3000 Louvain, Belgium
[6] Catholic Univ Louvain, B-3000 Louvain, Belgium
关键词
Lymphadenectomy; Lymph node dissection template; Lymph node staging; Prostate cancer; RADICAL RETROPUBIC PROSTATECTOMY; LYMPHADENECTOMY; DISSECTION;
D O I
10.1016/j.eururo.2012.06.057
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Opinions about the optimal lymph node dissection (LND) template in prostate cancer differ. Drainage and dissemination patterns are not necessarily identical. Objective: To present a precise overview of the lymphatic drainage pattern and to correlate those findings with dissemination patterns. We also investigated the relationship between the number of positive lymph nodes (LN+) and resected lymph nodes (LNs) per region. Design, setting, and participants: Seventy-four patients with localized prostate adenocarcinoma were prospectively enrolled. Patients did not show suspect LNs on computed tomography scan and had an LN involvement risk of >= 10% but <= 35% (Partin tables) or a cT3 tumor. Intervention: After intraprostatic technetium-99m nanocolloid injection, patients underwent planar scintigraphy and single-photon emission computed tomography imaging. Then surgery was performed, starting with a sentinel node (SN) procedure and a superextended lymphadenectomy followed by radical prostatectomy. Outcome measurements and statistical analysis: Distribution of scintigraphically detected SNs and removed SNs per region were registered. The number of LN+, as well as the percentage LN+ of the total number of removed LNs per region, was demonstrated in combining data of all patients. The impact of the extent of LND on N-staging and on the number of LN+ removed was calculated. Results and limitations: A total of 470 SNs were scintigraphically detected (median: 6; interquartile range [IQR]: 3-9), of which 371 SNs were removed (median: 4; IQR: 2.25-6). In total, 91 LN+(median: 2; IQR: 1-3) were found in 34 of 74 patients. The predominant site for LN+ was the internal iliac region. An extended LND(eLND) would have correctly staged 32 of 34 patients but would have adequately removed all LN+ in only 26 of 34 patients. When adding the presacral region, these numbers increased to 33 of 34 and 30 of 34 patients, respectively. Conclusions: Standard eLND would have correctly staged the majority of LN+ patients, but 13% of the LN+ would have been missed. Adding the presacral LNs to the template should be considered to obtain a minimal template with maximal gain. Note: This manuscript was invited based on the 2011 European Association of Urology meeting in Vienna. (C) 2012 European Association of Urology. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:450 / 458
页数:9
相关论文
共 50 条
  • [31] A narrative review of pelvic lymph node dissection in prostate cancer
    Cheung, Douglas C.
    Fleshner, Neil
    Sengupta, Shomik
    Woon, Dixon
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (06) : 3049 - 3055
  • [32] Current status of pelvic lymph node dissection in prostate cancer
    Aleksic I.
    Luthringer T.
    Mouraviev V.
    Albala D.M.
    Journal of Robotic Surgery, 2014, 8 (1) : 1 - 6
  • [33] Radioisotope guided pelvic lymph node dissection for prostate cancer
    Wawroschek, F
    Vogt, H
    Weckermann, D
    Wagner, T
    Hamm, M
    Harzmann, R
    JOURNAL OF UROLOGY, 2001, 166 (05): : 1715 - 1719
  • [34] Role of Pelvic Lymph Node Dissection in Prostate Cancer Treatment
    Joung, Jae Young
    Cho, In-Chang
    Lee, Kang Hyun
    KOREAN JOURNAL OF UROLOGY, 2011, 52 (07) : 437 - 445
  • [35] PELVIC LYMPH-NODE DISSECTION IN PROSTATE-CANCER
    GUINAN, P
    HABIBI, H
    SHARIFI, R
    RAY, P
    SHAW, M
    MOULI, K
    UROLOGY, 1984, 24 (06) : 540 - 543
  • [36] Extended laparoscopic pelvic lymph node (lnd) for prostate cancer
    Secin, F. P.
    Koppie, T.
    Touijer, K.
    Guillonneau, B.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 302 - 302
  • [37] Elective Pelvic Lymph Node Radiation in Prostate Cancer Revisited
    Yang, David D.
    Nguyen, Paul L.
    D'Amico, Anthony V.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (25) : 2845 - +
  • [38] Laparoscopic pelvic lymph node dissection in the staging of prostate cancer
    Stone, NN
    Stock, RG
    MOUNT SINAI JOURNAL OF MEDICINE, 1999, 66 (01): : 26 - 30
  • [39] Pelvic lymph node dissection in prostate cancer: Laparoscopy is not dead
    Semaan, A.
    El Helou, E.
    Tayeh, G. Abi
    Mjaess, G.
    Chebel, J. Abi
    Sarkis, J.
    ACTAS UROLOGICAS ESPANOLAS, 2020, 44 (10): : 682 - 691
  • [40] Indications and Trends in Pelvic Lymph Node Dissection for Prostate Cancer
    Djavan, Bob
    Kazzazi, Amir
    Dulabon, Lori
    Momtahen, Shabnam
    Dianat, Seyed Saeid
    Sand, Matthew
    Cheetham, Philippa
    Janetschek, Gunter
    Lepor, Herbert
    Graefen, Markus
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (03) : E38 - E43